RareWays is a research directory. It helps you understand the science. It is not medical advice. Always discuss your care options with your healthcare team.

Coverage: 2020-01-01 onwards, with up to 300 results per query from PubMed and Europe PMC and separate limits on other sources. This is a selected index, not a complete literature search.

Updates are delayed or unverified. Check original sources for the latest information.

Your saved research and appointment questions

View recorded trial and retraction changes

ICD L63ORPHA:701AA

Alopecia Areata

Alopecia areata is an autoimmune condition that causes unpredictable hair loss, ranging from small patches to complete loss of scalp or body hair. It can affect people of any age. Recent years have seen significant research advances, including new JAK inhibitor treatments now approved in several countries.

This overview is general information, not an individual medical assessment. Research is selected automatically and may include mismatches. How we select and explain research.

1,133
Articles
182
Trials (15 AU)
Data refreshed
19 October 2026
Loading...

Common Questions

What is Alopecia Areata?

Alopecia areata is an autoimmune condition that causes unpredictable hair loss, ranging from small patches to complete loss of scalp or body hair. It can affect people of any age. Recent years have seen significant research advances, including new JAK inhibitor treatments now approved in several countries.

How many clinical trials are available for Alopecia Areata?

RareWays currently indexes 182 clinical trials for Alopecia Areata, of which 24 are actively recruiting. These counts cover indexed trials across countries, not just your country. An Australian site does not necessarily mean that site is recruiting. Check locations, eligibility and current availability with the study team.

Where does the research data for Alopecia Areata come from?

RareWays aggregates research from PubMed, Europe PMC, OpenAlex, and ClinicalTrials.gov. Data is refreshed automatically every day. All articles and trials link directly to their original sources.

Get research updates

Monthly email when new findings are published for Alopecia Areata.

Your email and selected disease are stored for these updates. Unsubscribe any time. Privacy and deletion.

This information is for general awareness only.

For guidance specific to your situation, please speak with your healthcare team.